← Eichor
Study identifier: NCT04171856 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Exploring Motor Learning in Acute Stroke Through Robotics

Condition: Stroke, Acute  ·  Sponsor: University Hospital of Mont-Godinne

PhaseNA
Planned participants245
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersYes

About this study

The acute phase of stroke is characterized by an enhancement of neural plasticity which supports rapid motor recovery. It is unclear whether acute stroke patients can acquire new motor skills with their affected upper limb. The aims of this research program are: 1. To test the capacity of acute stroke patients (\< 21 days) to learn and retain a complex unimanual motor skill. 2. To explore whether acute stroke to different brain regions (quantified with brain MRI) induces specific deficits in motor skill learning. 3. To compare acute stroke patients with healthy individuals and with chronic stroke patients.

This description comes directly from the study's public registry record.

Talk to the study team

Yves Vandermeeren, MD, PhD  ·  +32 81 42 33 21  ·  yves.vandermeeren@uclouvain.be

Eloïse Gerardin, MSc  ·  +32 81 42 33 48  ·  eloise.gerardin@uclouvain.be

Always discuss trial participation with your own doctor first.

Locations (2)

CHU UCL NamurYvoir, Namur, BelgiumRecruiting
University Hospital CHU Dinant Godinne UCLYvoir, BelgiumNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04171856